Ufp Technologies (UFPT) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.48% |
| Dec 31, 2025 | 30.04% |
| Sep 30, 2025 | 41.54% |
| Jun 30, 2025 | 49.19% |
| Mar 31, 2025 | 33.79% |
| Dec 31, 2024 | 23.18% |
| Sep 30, 2024 | 28.96% |
| Jun 30, 2024 | 22.96% |
| Mar 31, 2024 | 26.24% |
| Dec 31, 2023 | 18.28% |
| Sep 30, 2023 | 20.24% |
| Jun 30, 2023 | 24.81% |
| Mar 31, 2023 | 38.12% |
| Dec 31, 2022 | -68.94% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 24.04% |
| Mar 31, 2022 | 13.48% |
| Dec 31, 2021 | 15.14% |
| Sep 30, 2021 | 4.25% |
| Jun 30, 2021 | 8.14% |
| Mar 31, 2021 | 25.29% |
| Dec 31, 2020 | -44.54% |
| Sep 30, 2020 | 3.89% |
| Jun 30, 2020 | -3.49% |
| Mar 31, 2020 | 13.22% |
| Dec 31, 2019 | 21.41% |
| Sep 30, 2019 | 13.35% |
| Jun 30, 2019 | 16.65% |
| Mar 31, 2019 | 8.55% |
| Dec 31, 2018 | -0.43% |
| Sep 30, 2018 | 4.85% |
| Jun 30, 2018 | 2.83% |
| Mar 31, 2018 | -4.09% |
| Dec 31, 2017 | -14.22% |
| Sep 30, 2017 | -8.86% |
| Jun 30, 2017 | -1.60% |
| Mar 31, 2017 | -2.51% |
| Dec 31, 2016 | -11.49% |
| Sep 30, 2016 | 4.73% |
| Jun 30, 2016 | -0.46% |
| Mar 31, 2016 | -15.21% |
| Dec 31, 2015 | -10.57% |
| Sep 30, 2015 | -4.05% |
| Jun 30, 2015 | -0.80% |